ARNATAR THERAPEUTICS CURE FOR CAUSE
Live / Allowed — Fifth extension granted (statement of use) (as of 20 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97594202
- Mark type
- Design + words
- Filed
- 16 Sept 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Andrew T. Rissler
Goods and services
- Class 005 — Pharmaceuticals: Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases
Owner
- Arnatar Therapeutics, Inc., San Diego, CA, US
- Arnatar Therapeutics, San Diego, CA, US
Prosecution history
- 28 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2026 — SOU EXTENSION 5 GRANTED
- 18 May 2026 — SOU EXTENSION 5 FILED
- 19 May 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2026 — SOU EXTENSION 4 GRANTED
- 21 Nov 2025 — SOU EXTENSION 4 FILED
- 16 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 16 Jan 2026 — PETITION TO REVIVE-GRANTED
- 16 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED